Simultaneous detection and quantification of DNA and protein biomarkers in spectrum of cardiovascular diseases in a microfluidic microbead chip

Abstract

The rapid and simultaneous detection of DNA and protein biomarkers is necessary to detect the outbreak of a disease or to monitor a disease. For example, cardiovascular diseases are a major cause of adult mortality worldwide. We have developed a rapidly adaptable platform to assess biomarkers using a microfluidic technology. Our model mimics autoantibodies against three proteins, C-reactive protein (CRP), brain natriuretic peptide (BNP), and low-density lipoprotein (LDL). Cell-free mitochondrial DNA (cfmDNA) and DNA controls are detected via fluorescence probes. The biomarkers are covalently bound on the surface of size- (11–15 μm) and dual-color encoded microbeads and immobilized as planar layer in a microfluidic chip flow cell. Binding events of target molecules were analyzed by fluorescence measurements with a fully automatized fluorescence microscope (end-point and real-time) developed in house. The model system was optimized for buffers and immobilization strategies of the microbeads to enable the simultaneous detection of protein and DNA biomarkers. All prime target molecules (anti-CRP, anti-BNP, anti-LDL, cfmDNA) and the controls were successfully detected both in independent reactions and simultaneously. In addition, the biomarkers could also be detected in spiked human serum in a similar way as in the optimized buffer system. The detection limit specified by the manufacturer is reduced by at least a factor of five for each biomarker as a result of the antibody detection and kinetic experiments indicate that nearly 50 % of the fluorescence intensity is achieved within 7 min. For rapid data inspection, we have developed the open source software digilogger, which can be applied for data evaluation and visualization. Graphical abstract Electronic supplementary materialThe online version of this article (10.1007/s00216-019-02199-x) contains supplementary material, which is available to authorized users.

A multiparametric fluorescence assay for screening aptamer–protein interactions based on microbeads

“…But we argue that the random orientation can also stochastically make accessible a portion that is usually sufficient for the generation of a measurement signal. This is also in line with our previous work 23 – 25 , where molecules were successfully bound.…”

“…The VideoScan technology can be used to analyse cell assays, microbead assays, assays in solution and various other combinations. Applications include approaches for human diagnostics 32 , point of care testing 23 and medical microbiology 33 . In our study, we covalently coupled a set of up to 17 different proteins by random amino-coupling individually to dye/size-encoded microbead populations and pooled them.…”

Single‐Molecule Bioelectronic Label‐Free Assay of both Protein and Genomic Markers of Pancreatic Mucinous Cysts’ in Whole Blood Serum

“…Hence, besides the elicited genomic markers, already detected at the physical limit by NGS, also proteins should be engaged. [ 14 ] In pancreatic cysts, the oncoprotein Mucin1 (MUC1) is expressed in cells of high‐grade precursors of cancer and often also in pancreatic cancer itself. Indeed, the expression of MUC1 is indicative of an aggressive phenotype related to a high frequency of metastases and a poor prognosis.…”

Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges

“…The method achieved faster detection speeds and higher detection accuracy than conventional immunoassay methods; however, the platform still requires supporting equipment for analysis, which may not be available in underdeveloped areas. We hope that this high-precision equipment could be miniaturized and produced inexpensively to allow for application in regions with weaker infrastructure [154].…”